Subcellular Localization and Quantification of Androgen Receptor in Hormone-Naive Prostatic Adenocarcinoma and Clinical Correlation

被引:0
|
作者
Huang, W.
Hoyt, C.
Pier, T.
Fletcher-Holmes, D.
机构
[1] Univ Wisconsin Madison, Madison, WI USA
[2] Cambridge Res & Instrumentat Inc, Woburn, MA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
838
引用
收藏
页码:199A / 199A
页数:1
相关论文
共 50 条
  • [21] RELATIONSHIP BETWEEN NUCLEAR ANDROGEN RECEPTOR (AR) CONCENTRATION AND CLINICAL-RESPONSE TO ENDOCRINE THERAPY FOR PROSTATIC ADENOCARCINOMA
    FENTIE, DD
    LAKEY, WH
    MCBLAIN, WA
    PROSTATE, 1984, 5 (03): : 331 - 332
  • [22] AZGP1 Protein Expression in Hormone-Naive Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy
    Winther, Mads Dochedahl
    Kristensen, Gitte
    Stroomberg, Hein Vincent
    Berg, Kasper Drimer
    Toft, Birgitte Gronkaer
    Brooks, James D.
    Brasso, Klaus
    Roder, Martin Andreas
    DIAGNOSTICS, 2020, 10 (08)
  • [23] Correlation of Neuroendocrine Differentiation and Androgen Receptor Status in Prostate Adenocarcinoma
    Sadimin, E. T.
    Lee, G. T.
    May, M. S.
    Kim, I. Y.
    LABORATORY INVESTIGATION, 2014, 94 : 257A - 258A
  • [24] Correlation of Neuroendocrine Differentiation and Androgen Receptor Status in Prostate Adenocarcinoma
    Sadimin, E.
    Lee, G. T.
    May, M. S.
    Kim, I. Y.
    MODERN PATHOLOGY, 2014, 27 : 257A - 258A
  • [25] Subcellular localization modulates activation function 1 domain phosphorylation in the androgen receptor
    Kesler, Cristina T.
    Gioeli, Daniel
    Conaway, Mark R.
    Weber, Michael J.
    Paschal, Bryce M.
    MOLECULAR ENDOCRINOLOGY, 2007, 21 (09) : 2071 - 2084
  • [26] Androgen receptor expression in hormone refractory prostate cancer from a rapid autopsy series: Quantitative subcellular localization using AQUA
    Azabdaftari, G
    Shah, R
    Bismar, TA
    Kim, R
    Zerkowski, MP
    Rimm, D
    Pienta, KJ
    LABORATORY INVESTIGATION, 2005, 85 : 5A - 5A
  • [27] Androgen receptor expression in hormone refractory prostate cancer from a rapid autopsy series: Quantitative subcellular localization using AQUA
    Azabdaftari, G
    Shah, R
    Bismar, TA
    Kim, R
    Zerkowski, MP
    Rimm, S
    Pienta, KJ
    Rubin, MA
    MODERN PATHOLOGY, 2005, 18 : 5A - 5A
  • [28] Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma
    Blandamura, Stella
    Alessandrini, Lara
    Saccardi, Carlo
    Giacomelli, Luciano
    Fabris, Alberta
    Borghero, Angela
    Litta, Pietro
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (06) : 777 - 783
  • [29] Clinical and prognostic significance of changes in haemoglobin concentration during 1 year of androgen-deprivation therapy for hormone-naive bone-metastatic prostate cancer
    Ebbinge, Maria
    Berglund, Anders
    Section, Eberhard Varenhorst
    Hedlund, Per Olov
    Sandblom, Gabriel
    BJU INTERNATIONAL, 2018, 122 (04) : 583 - 591
  • [30] Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naive prostate cancer: Single institution experience.
    Rayner, Lindsay Jennifer Andrew
    Challapalli, Amarnath
    Blackmore, Eve
    Rea, Katherine
    Wells, Natasha
    White, Paul
    Hilman, Serena
    Masson, Susan
    Huckett, Rebecca
    Garadi, Krishna
    Kirk, Hannah
    Kabala, Julian
    Oikonomopoulou, Viktoria
    Bahl, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)